SelectScience
Join Free
NewsClinical Diagnostics

GATC Biotech’s Liquid Biopsy Testing Starts from as Little as EUR 195 Per Sample

GATC Biotech

GATC Biotech takes also the lead in terms of costs of liquid biopsy testing supporting early implementation of such assays by providing easy technology accessibility to researchers in clinical and translational medicine

23 Mar 2016
Lois Manton-O'Byrne, PhD
Executive Editor

Product news

GATC Biotech AG, a world-wide leading provider of advanced genome analysis and diagnostic services, has announced the pricing of the company’s liquid biopsy-based services - ONCOEXOME, ONCOPANEL and ONCOTARGET. The prices, released during this week’s 10th International Symposium on Minimal Residual Cancer (ISMRC), start from as little as EUR 195 per sample.

“By adopting this highly competitive pricing strategy, we are responding to the market’s demand for greater accessibility to our liquid biopsy technology. Clinicians can now quickly and accurately characterize cancer so that they can react to this progressive disease in a timely manner,” said Peter Pohl, CEO and co-founder of GATC Biotech.

The three GATCLIQUID services allow highly sensitive detection of genomic alterations in circulating tumor DNA (ctDNA) to capture the entire heterogeneity of cancer. They provide clinical researchers the opportunity to interrogate a whole range of tumor-related mutations that help characterize a patient’s cancer from a simple blood sample.

“As cancer evolves, so must the tools to fight the disease with greater effectiveness,” added Dr Marcus Benz, COO of GATC Biotech. “Due to excellent performance standards, the GATCLIQUID services are poised to play a key role in revolutionizing blood-based cancer research and diagnostics.” By avoiding risk-prone and painful re-biopsies, GATCLIQUID is well-suited for treatment monitoring and therapy decision making in cases of cancer recurrence. ONCOTARGET can be effectively applied to reveal additional therapeutic options for patients with cancer relapse or acquired drug resistance.

“We are proud partners with the oncology community, and this latest move is driven by the desire to facilitate greater physician and patient accessibility to evaluative testing that leads to truly effective treatment. The advantages of liquid biopsy combined with our pricing make GATCLIQUID an ideal tool for monitoring a patient’s cancer at close intervals,” added Peter Pohl.

The GATCLIQUID services are available at the following net prices per sample:

ONCOTARGET for EUR 195 | ONCOPANEL for EUR 1,450 | ONCOEXOME for EUR 2,950

All samples are processed at GATC Biotech’s own laboratories under ISO 17025 accreditation and ISO 13485 certification. GATCLIQUID is applicable to patients with solid tumors, such as lung, skin, breast, intestinal or ovarian cancer.

Links

GATC BiotechCompany website

Tags

HematologyIn Haematology / Hematology, complete blood cell counts (or full blood counts) are obtained using automated blood count analyzers to enumerate blood cell types.  Hematology also encompasses haemostasis and coagulation, thrombophilia and hemophilia, plasma viscosity and ESR analysis, hemoglobinopathies, cell morphology and haematinic measurement.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Cancer DiagnosticsThere are a wide variety of diagnostic tests for cancer available, and this range continues to expand as our knowledge of cancer improves. Current diagnostic methods include biopsy, imaging and blood tests for known biomarkers. New methods in research development include liquid biopsies and cancer breathalyzers.Translational MedicineBlood AnalysisThe analysis of blood is vital for many areas of life sciences and forensic investigations. Blood samples can be tested for a number of different reasons such as diagnosis, glucose levels, cholesterol and drug testing.TumorsTumor research focuses on understanding abnormal cell growth that leads to cancer. Identifying biomarkers, studying tumor microenvironments, and developing targeted therapies are critical for advancing cancer treatment. Early detection and personalized treatment options are key to improving outcomes for patients. Browse our peer-reviewed product directory to explore tools for tumor research, diagnostics, and cancer therapies; compare products, read customer reviews, and get pricing directly from manufacturers.Liquid BiopsiesLiquid biopsies are non-invasive tests used to detect cancer and other diseases by analyzing blood or other bodily fluids. This technique is gaining popularity for early detection, monitoring treatment response, and detecting minimal residual disease. Explore liquid biopsy solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Cancer ResearchAlthough cancer is often referred to as a single condition, it actually consists of more than 100 different diseases. Microscopy, mass spectrometry, high throughput sequencing and flow cytometry are some of the most common techniques employed in cancer research labs.

Related articles